161 related articles for article (PubMed ID: 37082886)
1. Association of frequent hypermethylation with high grade histological subtype in lung adenocarcinoma.
Ito Y; Usui G; Seki M; Fukuyo M; Matsusaka K; Hoshii T; Sata Y; Morimoto J; Hata A; Nakajima T; Rahmutulla B; Kaiho T; Inage T; Tanaka K; Sakairi Y; Suzuki H; Yoshino I; Kaneda A
Cancer Sci; 2023 Jul; 114(7):3003-3013. PubMed ID: 37082886
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the stomach and esophagogastric junction with low DNA methylation show poor prognoses.
Urabe M; Matsusaka K; Ushiku T; Fukuyo M; Rahmutulla B; Yamashita H; Seto Y; Fukayama M; Kaneda A
Gastric Cancer; 2023 Jan; 26(1):95-107. PubMed ID: 36224483
[TBL] [Abstract][Full Text] [Related]
3. A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis.
Hata A; Nakajima T; Matsusaka K; Fukuyo M; Morimoto J; Yamamoto T; Sakairi Y; Rahmutulla B; Ota S; Wada H; Suzuki H; Matsubara H; Yoshino I; Kaneda A
Int J Cancer; 2020 Jan; 146(2):388-399. PubMed ID: 31241180
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancer.
Takane K; Akagi K; Fukuyo M; Yagi K; Takayama T; Kaneda A
Cancer Med; 2017 May; 6(5):1023-1035. PubMed ID: 28378457
[TBL] [Abstract][Full Text] [Related]
5. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2022 Sep; 13(17):2473-2479. PubMed ID: 35820717
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary adenocarcinoma with high-grade fetal adenocarcinoma component has a poor prognosis, comparable to that of micropapillary adenocarcinoma.
Suzuki M; Nakatani Y; Ito H; Narimatsu H; Yamada K; Yoshioka E; Washimi K; Okubo Y; Kawachi K; Miyagi Y; Yokose T
Mod Pathol; 2018 Sep; 31(9):1404-1417. PubMed ID: 29785018
[TBL] [Abstract][Full Text] [Related]
8. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
[TBL] [Abstract][Full Text] [Related]
9. Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis.
Ito M; Miyata Y; Tsutani Y; Ito H; Nakayama H; Imai K; Ikeda N; Okada M
Lung Cancer; 2020 Mar; 141():107-113. PubMed ID: 32035371
[TBL] [Abstract][Full Text] [Related]
10. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
[TBL] [Abstract][Full Text] [Related]
11. High expression of CXCL14 is a biomarker of lung adenocarcinoma with micropapillary pattern.
Sata Y; Nakajima T; Fukuyo M; Matsusaka K; Hata A; Morimoto J; Rahmutulla B; Ito Y; Suzuki H; Yoshino I; Kaneda A
Cancer Sci; 2020 Jul; 111(7):2588-2597. PubMed ID: 32403160
[TBL] [Abstract][Full Text] [Related]
12. Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients.
Chao L; Yi-Sheng H; Yu C; Li-Xu Y; Xin-Lan L; Dong-Lan L; Jie C; Yi-Lon W; Hui LY
Lung Cancer; 2014 Nov; 86(2):164-9. PubMed ID: 25236981
[TBL] [Abstract][Full Text] [Related]
13. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
Yang K; Wu Y
BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
[TBL] [Abstract][Full Text] [Related]
14. Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes.
Kaneda A; Yagi K
Cancer Sci; 2011 Jan; 102(1):18-24. PubMed ID: 21159060
[TBL] [Abstract][Full Text] [Related]
15. The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis.
Takane K; Fukuyo M; Matsusaka K; Ota S; Rahmutulla B; Matsushita K; Miyauchi H; Nakatani Y; Matsubara H; Kaneda A
Oncotarget; 2018 Aug; 9(66):32653-32666. PubMed ID: 30220972
[TBL] [Abstract][Full Text] [Related]
16. Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis.
Karpinski P; Szmida E; Misiak B; Ramsey D; Leszczynski P; Bebenek M; Sedziak T; Grzebieniak Z; Jonkisz A; Lebioda A; Sasiadek MM
Mol Carcinog; 2012 Dec; 51(12):1003-8. PubMed ID: 22006538
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
18. [Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].
Zhang H; Sun FH; Chen ZC; Wang Q
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):580-586. PubMed ID: 35658346
[No Abstract] [Full Text] [Related]
19. Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.
Sun Y; Yu X; Shi X; Hong W; Zhao J; Shi L
World J Surg Oncol; 2014 May; 12():148. PubMed ID: 24885205
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.
Sato T; Arai E; Kohno T; Tsuta K; Watanabe S; Soejima K; Betsuyaku T; Kanai Y
PLoS One; 2013; 8(3):e59444. PubMed ID: 23544068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
